0000899243-18-024031.txt : 20180907 0000899243-18-024031.hdr.sgml : 20180907 20180907182424 ACCESSION NUMBER: 0000899243-18-024031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180131 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOCKERY CARL CENTRAL INDEX KEY: 0001618149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 181061042 MAIL ADDRESS: STREET 1: P.O. BOX 2477 CITY: LAKELAND STATE: FL ZIP: 33806-2477 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-31 0 0001175680 CytoDyn Inc. CYDY 0001618149 DOCKERY CARL 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Warrants (right to buy) 1.00 2018-01-31 4 D 0 33333 D 2017-07-28 2022-07-28 Common Stock 33333 0 I See footnote Warrants (right to buy) 0.75 2018-01-31 4 A 0 33333 A 2018-01-31 2022-07-28 Common Stock 33333 33333 I See footnote The two transactions reported in Table II above involved the amendment of an outstanding warrant to reduce the exercise price from $1 per share to $0.75 per share. The amendment is reported above as the cancellation of the "old" warrant and the acquisition of a new one. The reporting person is the sole member of Alpha Advisors, LLC, the investment advisor for Alpha Venture Capital Partners, LP ("AVCP"), and the managing member of Alpha Venture Capital Management, LLC, the general partner of AVCP. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest in such securities. /s/ Michael D. Mulholland, as attorney-in-fact 2018-09-07